Abzyme is developing a pipeline of monospecific and bispecific antibodies for the treatment of human and animal diseases.
![](https://abzymetx.com/wp-content/uploads/2024/06/Lisa-slides_Pipelines.jpg)
Impacting the research, diagnosis and treatment of human diseases through our novel antibody discovery and optimization platform